Clarivate Analytics (Us) LLC

Clarivate Analytics (Us) LLC, a foreign-owned for-profit subsidiary of Reuters News & Media Inc., supplies scientific research databases, bibliographic management software, patent analytics platforms, and specialized data products to civilian and defense federal agencies as a prime contractor on full-and-open competitive basis. The vendor does not compete under set-asides and operates primarily through sole-source and competitive delivery orders against existing indefinite delivery contracts rather than through direct prime awards.

Clarivate's federal capability footprint centers on subscription-based access to proprietary research infrastructure: the Web of Science citation indexing and analytics platform; EndNote bibliographic management software; InCites research benchmarking and analytics tools; Cortellis Drug Discovery Intelligence and specialized pharmaceutical databases; and custom data feeds including XML-formatted science, technology, and patent literature. Recent representative work includes a $10.46 million definitive contract with the U.S. Patent and Trademark Office for artificial intelligence-assisted design patent image search (awarded February 2024, completion August 2027); a $3.6 million five-year contract with the Office of the Secretary of Defense for extensible markup language data feeds covering 80 million records of open-source science, technology, and patent literature (awarded December 2021); a $2.32 million five-year contract with the Food and Drug Administration for biomarker database search solutions supporting drug development qualification (awarded September 2021); and a $1.58 million Web of Science perpetual license renewal with the Department of Energy Office of Science (awarded May 2025).

Customer concentration is moderate across research-intensive civilian agencies. The top five customers by award count account for 14 percent of all awards: the National Oceanic and Atmospheric Administration (40 awards, $2.6 million), National Institute of Standards and Technology (40 awards, $5.7 million), CDC Pittsburgh (33 awards, $3 million), NIH Office of Logistics and Acquisition Operations (31 awards, $28.7 million), and the Navy Bureau of Medicine and Surgery (26 awards, $874 thousand). By potential dollar value, the customer profile shifts toward the U.S. Patent and Trademark Office (20 awards, $98.4 million), NIH Office of Logistics and Acquisition Operations (31 awards, $28.7 million), NIH Office of the Director (25 awards, $8.7 million), FDA (25 awards, $8.5 million), and USDA Agricultural Research Service (23 awards, $6.9 million). The vendor operates across 157 distinct federal customer agencies with $2.31 billion in combined potential value across 1,224 awards.

Clarivate holds three significant indefinite delivery contracts anchoring its federal presence. A $200 million single-award IDC with the Library of Congress FEDLINK program (completion September 2026) provides commercial electronic information resources and document delivery to multiple civilian agencies; 30 task orders under this vehicle carry $32 million in combined potential value. A $34.9 million single-award IDC with the Department of the Army (completion September 2029) supports Army research, analysis, and program evaluation; the vendor issued a $1.8 million delivery order (IPT2 Task Order 0001) under this vehicle in September 2024 with completion April 2026. A $9.87 million single-award IDC with NIH Office of Logistics and Acquisition Operations (completion December 2026) funds Web of Science, EndNote, and InCites access across multiple NIH institutes; quarterly to semi-annual delivery orders under this vehicle range from $274 thousand to $650 thousand. Additional parent vehicles include an $11 million NIH contract and multiple smaller agency-specific indefinite delivery contracts with USPTO, DHS, and others.

Award activity has remained relatively flat over the past five fiscal years (42 awards in 2022 declining to 9 in 2026 year-to-date), with 34 awards carrying combined potential value of $25.6 million reaching ultimate completion inside the next twenty-four months, representing significant recompete exposure against incumbent status on renewal subscriptions and task orders.

SCI-reported invoiced revenue for federal service contracts above the $150,000 threshold totaled $20.8 million across FY2022–FY2024 ($5.7 million FY2022, $7.7 million FY2023, $7.4 million FY2024). The vendor reported 0.5 FTEs on federal service contracts in FY2022 and zero FTEs in FY2023 and FY2024, indicating that SCI-reportable effort is minimal and the vendor's federal delivery is largely product-based (subscriptions and licensed access) rather than labor-intensive services. Across SCI prime contracts, subcontractors account for zero percent of total hours, and the vendor names one subcontractor across the broader SCI dataset, signaling that Clarivate builds and delivers research infrastructure tools using its own personnel and proprietary systems rather than relying on sub-award teaming. The vendor operates as a pure prime on its federal footprint (100 percent of awards) with negligible sub-award activity (three sub-awards identified across 1,224 total awards, representing less than 0.3 percent), indicating Clarivate does not function as a feeder vendor to other primes in the federal space.